US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cellyan Biotechnology Co Ltd

0.3720

-0.0367-8.98%

Post-market: 0.37200.00000.00%16:00 EDT

Volume:311.68K

Turnover:120.60K

Market Cap:18.04M

PE:-7.70

High:0.4183

Open:0.3976

Low:0.3700

Close:0.4087

52wk High:2.58

52wk Low:0.3100

Shares:48.50M

Float Shares:40.71M

Volume Ratio:1.53

T/O Rate:0.77%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0483

EPS(LYR):-0.0483

ROE:-15.59%

ROA:-5.64%

PB:1.88

PE(LYR):-7.70

Loading ...

Overview Company News Filings

Cellyan FY26 Net Loss Widens to $1.14 Million; Revenue Falls 34% to $13.43 Million

Cellyan Biotechnology Co Ltd: Files for Non Timely 20-F - SEC Filing

THOMSON REUTERS

Cellyan Biotechnology Co Ltd: Expects to Report Net Loss of About $1.09 Million for Year Ended March 31, 2026

THOMSON REUTERS

Cellyan Biotechnology Flags Delay in Filing Annual Form 20-F for FY Ended March 31, 2026

Top Premarket Decliners

MT Newswires Live

Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule

MT Newswires Live

Cellyan Biotechnology Co., Ltd Receives NASDAQ Notice of Additional Compliance Grace Period

THOMSON REUTERS

Cellyan Biotechnology Files $200 Million Mixed Shelf

MT Newswires Live

Cellyan Biotechnology files $200M mixed securities shelf

Cellyan Biotechnology director Chan Kam Leung files initial beneficial ownership statement

Cellyan Biotechnology files Form 3 showing director Wong Lap Sun stake of 18,468 shares

Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement

Indef: EV Tax Policy Creates Loopholes for Tax Avoidance

BRIEF-Cellyan Biotechnology Says Selling Shareholders May Offer 12.5 Mln Class A Ordinary Shares

Cellyan Biotechnology Co. files to sell 12.5M Class A ordinary shares for holder

Cellyan Biotechnology Co Ltd - Selling Shareholders May Offer up to 12.5 Mln Class a Ordinary Shares From Time to Time - SEC Filing

THOMSON REUTERS

Cellyan Biotechnology sells 12,499,986 units in private placement; gross proceeds rise to $7 million

Cellyan Biotechnology H1 FY2025 revenue fell 36% to USD 7.14 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/HKPD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HKPD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKPD\",,,,,undefined,":{"symbol":"HKPD","market":"US","secType":"STK","nameCN":"Cellyan Biotechnology Co Ltd","latestPrice":0.372,"timestamp":1787601600000,"preClose":0.4087,"halted":0,"volume":311681,"hourTrading":{"tag":"盘后","latestPrice":0.372,"preClose":0.372,"latestTime":"16:00 EDT","volume":9,"amount":3.348,"timestamp":1787601601338,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08979691705407392,"floatShares":40713600,"shares":48500000,"eps":-0.048338,"marketStatus":"Post-Mkt","change":-0.0367,"latestTime":"08-24 16:03:46 EDT","open":0.3976,"high":0.4183,"low":0.37,"amount":120597,"amplitude":0.11818,"askPrice":0.4559,"askSize":100,"bidPrice":0.37,"bidSize":24,"shortable":3,"etf":0,"ttmEps":-0.048338,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"listingDate":1736917200000,"exchange":"NASDAQ","adjPreClose":0.4087,"preHourTrading":{"tag":"盘前","latestPrice":0.41,"preClose":0.4087,"latestTime":"07:10 EDT","volume":1333,"amount":532.0858786,"timestamp":1787569820238,"change":0.0013,"changeRate":0.003181,"amplitude":0.03034},"postHourTrading":{"tag":"盘后","latestPrice":0.372,"preClose":0.372,"latestTime":"16:00 EDT","volume":9,"amount":3.348,"timestamp":1787601601338,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.534977},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HKPD\",,,,,undefined,":{"symbol":"HKPD","floatShares":40713600,"roa":"-5.64%","roe":"-15.59%","lyrEps":-0.048338,"volumeRatio":1.534977,"shares":48500000,"dividePrice":0,"high":0.4183,"amplitude":0.11818,"preClose":0.4087,"low":0.37,"week52Low":0.31,"pbRate":"1.88","psRate":"1.34","week52High":2.58,"institutionHeld":0,"latestPrice":0.372,"committee":-0.612903,"eps":-0.048338,"divideRate":0,"volume":311681,"delay":0,"ttmEps":-0.048338,"open":0.3976,"prevYearClose":0.8244,"prevWeekClose":0.4087,"prevMonthClose":0.4425,"prevQuarterClose":0.38,"fiveDayClose":0.4121,"twentyDayClose":0.4165,"sixtyDayClose":0.525},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HKPD\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HKPD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HKPD\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HKPD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HKPD","date":"2026-08-21","current":-8.004055,"percent":0.625,"low":-707.421644,"twenty":-337.041691,"median":-15.518668,"eighty":7.662739,"high":33.089748,"avg":-152.669709,"sd":210.334177,"marketCap":9611494},"quantilePoints":[{"date":"2025-01-17","current":22.252855,"twenty":22.683022,"median":23.328272,"eighty":29.185158,"marketCap":29590000},{"date":"2025-01-24","current":19.853849,"twenty":22.163513,"median":22.749202,"eighty":23.295182,"marketCap":26400000},{"date":"2025-01-31","current":16.793047,"twenty":18.563348,"median":20.997513,"eighty":23.080099,"marketCap":22330000},{"date":"2025-02-07","current":15.061626,"twenty":16.544874,"median":19.357502,"eighty":22.649933,"marketCap":20027700},{"date":"2025-02-14","current":18.199361,"twenty":16.346336,"median":18.054593,"eighty":22.230519,"marketCap":24200000},{"date":"2025-02-21","current":14.642213,"twenty":16.048528,"median":17.04122,"eighty":22.141177,"marketCap":19470000},{"date":"2025-02-28","current":14.642213,"twenty":14.973111,"median":16.544874,"eighty":19.853849,"marketCap":19470000},{"date":"2025-03-07","current":11.250514,"twenty":14.559489,"median":16.503512,"eighty":19.522951,"marketCap":14960000},{"date":"2025-03-14","current":9.781329,"twenty":11.950362,"median":16.048528,"eighty":19.357502,"marketCap":13006400},{"date":"2025-03-21","current":11.250514,"twenty":11.250514,"median":15.182817,"eighty":18.36481,"marketCap":14960000},{"date":"2025-03-28","current":10.588719,"twenty":11.002341,"median":14.650486,"eighty":18.199361,"marketCap":14080000},{"date":"2025-04-04","current":6.395218,"twenty":10.081619,"median":14.600851,"eighty":17.909826,"marketCap":12210000},{"date":"2025-04-11","current":6.049531,"twenty":9.596027,"median":14.311316,"eighty":17.289393,"marketCap":11550000},{"date":"2025-04-17","current":5.934302,"twenty":7.317051,"median":11.950362,"eighty":16.892316,"marketCap":11330000},{"date":"2025-04-25","current":5.588614,"twenty":6.870884,"median":11.581412,"eighty":16.660688,"marketCap":10670000},{"date":"2025-05-02","current":6.856135,"twenty":6.383119,"median":11.250514,"eighty":16.561419,"marketCap":13090000},{"date":"2025-05-09","current":5.12885,"twenty":6.199328,"median":11.126428,"eighty":16.544874,"marketCap":9792200},{"date":"2025-05-16","current":5.819072,"twenty":6.095622,"median":10.505995,"eighty":16.544874,"marketCap":11110000},{"date":"2025-05-23","current":5.761458,"twenty":5.922664,"median":10.004271,"eighty":16.478694,"marketCap":11000000},{"date":"2025-05-30","current":6.279989,"twenty":6.003439,"median":9.854126,"eighty":16.36288,"marketCap":11990000},{"date":"2025-06-06","current":9.448791,"twenty":6.084099,"median":9.596027,"eighty":16.147797,"marketCap":18040000},{"date":"2025-06-13","current":10.370624,"twenty":6.107145,"median":9.926924,"eighty":16.048031,"marketCap":19800000},{"date":"2025-06-20","current":8.584572,"twenty":6.107145,"median":9.688678,"eighty":15.750223,"marketCap":16390000},{"date":"2025-06-27","current":8.18127,"twenty":6.130191,"median":9.448791,"eighty":15.207055,"marketCap":15620000},{"date":"2025-07-03","current":7.489895,"twenty":6.16476,"median":9.275947,"eighty":15.043923,"marketCap":14300000},{"date":"2025-07-11","current":7.835583,"twenty":6.176283,"median":8.9448,"eighty":14.908586,"marketCap":14960000},{"date":"2025-07-18","current":8.008426,"twenty":6.222374,"median":8.584572,"eighty":14.648831,"marketCap":15290000},{"date":"2025-07-25","current":7.432281,"twenty":6.222374,"median":8.440535,"eighty":14.642213,"marketCap":14190000},{"date":"2025-08-01","current":6.225831,"twenty":6.223065,"median":8.18127,"eighty":14.625668,"marketCap":11886600},{"date":"2025-08-08","current":6.568062,"twenty":6.223065,"median":8.008426,"eighty":14.509854,"marketCap":12540000},{"date":"2025-08-15","current":6.107145,"twenty":6.222374,"median":7.950812,"eighty":14.311316,"marketCap":11660000},{"date":"2025-08-22","current":-398.43288,"twenty":6.176283,"median":7.86439,"eighty":14.103181,"marketCap":10780000},{"date":"2025-08-29","current":-654.568303,"twenty":6.107145,"median":7.835583,"eighty":13.093941,"marketCap":17710000},{"date":"2025-09-05","current":-422.82673,"twenty":5.934302,"median":7.662739,"eighty":12.387134,"marketCap":11440000},{"date":"2025-09-12","current":-552.927262,"twenty":5.760882,"median":7.518702,"eighty":11.950362,"marketCap":14960000},{"date":"2025-09-19","current":-548.86162,"twenty":5.588614,"median":7.432281,"eighty":11.912309,"marketCap":14850000},{"date":"2025-09-26","current":-707.421644,"twenty":5.25445,"median":7.374666,"eighty":11.581412,"marketCap":19140000},{"date":"2025-10-03","current":-552.927262,"twenty":5.128274,"median":7.317051,"eighty":11.581412,"marketCap":14960000},{"date":"2025-10-10","current":-530.566233,"twenty":-410.629805,"median":7.000171,"eighty":11.415963,"marketCap":14355000},{"date":"2025-10-17","current":-487.876996,"twenty":-426.892371,"median":6.913749,"eighty":11.407687,"marketCap":13200000},{"date":"2025-10-24","current":-695.224719,"twenty":-471.614429,"median":6.856135,"eighty":11.250514,"marketCap":18810000},{"date":"2025-10-31","current":-512.270846,"twenty":-487.876996,"median":6.740906,"eighty":11.250514,"marketCap":13860000},{"date":"2025-11-07","current":-487.876996,"twenty":-491.942637,"median":6.576704,"eighty":11.250514,"marketCap":13200000},{"date":"2025-11-14","current":-479.745713,"twenty":-496.008279,"median":6.510447,"eighty":11.002341,"marketCap":12980000},{"date":"2025-11-21","current":-414.695446,"twenty":-491.942637,"median":6.396083,"eighty":10.94677,"marketCap":11220000},{"date":"2025-11-28","current":-401.563424,"twenty":-491.942637,"median":6.395218,"eighty":10.716312,"marketCap":10864700},{"date":"2025-12-05","current":-327.690716,"twenty":-488.690124,"median":6.334723,"eighty":10.602715,"marketCap":8866000},{"date":"2025-12-12","current":-324.763454,"twenty":-487.876996,"median":6.228712,"eighty":10.52254,"marketCap":8786800},{"date":"2025-12-19","current":-283.781379,"twenty":-487.876996,"median":6.222374,"eighty":10.397698,"marketCap":7677989},{"date":"2025-12-26","current":-304.882466,"twenty":-487.876996,"median":6.222374,"eighty":10.370624,"marketCap":8248900},{"date":"2026-01-02","current":-335.171496,"twenty":-487.876996,"median":6.16476,"eighty":10.325503,"marketCap":9068400},{"date":"2026-01-09","current":-317.120047,"twenty":-487.063868,"median":6.107145,"eighty":10.187341,"marketCap":8580000},{"date":"2026-01-16","current":-324.031638,"twenty":-485.031047,"median":6.107145,"eighty":10.019741,"marketCap":8767000},{"date":"2026-01-23","current":-325.007392,"twenty":-483.811354,"median":5.934302,"eighty":9.926924,"marketCap":8793400},{"date":"2026-01-30","current":-325.495269,"twenty":-482.998226,"median":5.790265,"eighty":9.897805,"marketCap":8806600},{"date":"2026-02-06","current":-337.326286,"twenty":-479.745713,"median":5.755696,"eighty":9.744269,"marketCap":9126700},{"date":"2026-02-13","current":-318.33974,"twenty":-479.745713,"median":5.641908,"eighty":9.579482,"marketCap":8613000},{"date":"2026-02-20","current":-283.659817,"twenty":-479.745713,"median":5.472809,"eighty":9.513302,"marketCap":7674700},{"date":"2026-02-27","current":-264.266706,"twenty":-479.745713,"median":5.25445,"eighty":9.448791,"marketCap":7150000},{"date":"2026-03-06","current":-271.584861,"twenty":-479.745713,"median":5.156217,"eighty":9.448791,"marketCap":7348000},{"date":"2026-03-13","current":-260.973536,"twenty":-471.614429,"median":5.127697,"eighty":9.275947,"marketCap":7060900},{"date":"2026-03-20","current":-252.069781,"twenty":-455.351863,"median":-249.650724,"eighty":9.103103,"marketCap":6820000},{"date":"2026-03-27","current":-10.343648,"twenty":-435.023655,"median":-10.343648,"eighty":9.016956,"marketCap":7260000},{"date":"2026-04-02","current":-19.000744,"twenty":-433.397398,"median":-18.73624,"eighty":8.901507,"marketCap":13336242},{"date":"2026-04-10","current":-18.649188,"twenty":-428.112064,"median":-18.692714,"eighty":8.780462,"marketCap":13089492},{"date":"2026-04-17","current":-23.437041,"twenty":-426.892371,"median":-19.000744,"eighty":8.619141,"marketCap":16449990},{"date":"2026-04-24","current":-20.858966,"twenty":-423.769958,"median":-19.938242,"eighty":8.538481,"marketCap":14640491},{"date":"2026-05-01","current":-20.925929,"twenty":-422.859255,"median":-20.925929,"eighty":8.480866,"marketCap":14687491},{"date":"2026-05-08","current":-21.428152,"twenty":-422.82673,"median":-21.346122,"eighty":8.423251,"marketCap":15039991},{"date":"2026-05-15","current":-19.084447,"twenty":-416.321703,"median":-20.925929,"eighty":8.227362,"marketCap":13394992},{"date":"2026-05-22","current":-18.414817,"twenty":-411.442933,"median":-20.832197,"eighty":8.18127,"marketCap":12924992},{"date":"2026-05-29","current":-17.57778,"twenty":-410.629805,"median":-19.847825,"eighty":8.146702,"marketCap":12337492},{"date":"2026-06-05","current":-16.914846,"twenty":-405.189976,"median":-19.084447,"eighty":8.054518,"marketCap":11872192},{"date":"2026-06-12","current":-15.033187,"twenty":-401.563424,"median":-19.017485,"eighty":8.008426,"marketCap":10551493},{"date":"2026-06-18","current":-13.74415,"twenty":-400.311206,"median":-18.749632,"eighty":7.98538,"marketCap":9646744},{"date":"2026-06-26","current":-12.42163,"twenty":-398.43288,"median":-18.649188,"eighty":7.950812,"marketCap":8718494},{"date":"2026-07-02","current":-13.560002,"twenty":-392.740982,"median":-18.411469,"eighty":7.939289,"marketCap":9517494},{"date":"2026-07-10","current":-15.167113,"twenty":-367.208753,"median":-18.090046,"eighty":7.893197,"marketCap":10645493},{"date":"2026-07-17","current":-14.413779,"twenty":-354.64592,"median":-17.751884,"eighty":7.881674,"marketCap":10116743},{"date":"2026-07-24","current":-11.082372,"twenty":-347.937611,"median":-17.57778,"eighty":7.835583,"marketCap":7778495},{"date":"2026-07-31","current":-13.657098,"twenty":-345.172975,"median":-17.432135,"eighty":7.835583,"marketCap":9585644},{"date":"2026-08-07","current":-13.717365,"twenty":-343.018185,"median":-17.154172,"eighty":7.835583,"marketCap":9627944},{"date":"2026-08-14","current":-8.688658,"twenty":-337.326286,"median":-16.469544,"eighty":7.825788,"marketCap":9869994},{"date":"2026-08-21","current":-8.461098,"twenty":-337.041691,"median":-15.518668,"eighty":7.662739,"marketCap":9611494}],"updateTime":1787597811995},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HKPD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657466626","title":"Cellyan FY26 Net Loss Widens to $1.14 Million; Revenue Falls 34% to $13.43 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657466626","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657466626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:32","pubTimestamp":1786134777,"startTime":"0","endTime":"0","summary":"Cellyan FY26 net loss widens to $1.14 million; revenue falls 34% to $13.43 millionCellyan Biotechnology posted a net loss of $1.14 million, widening from a net loss of $27,056.Revenue fell 34% to $13.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL9qNCrz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656754399","title":"Cellyan Biotechnology Co Ltd: Files for Non Timely 20-F - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656754399","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656754399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656399053","title":"Cellyan Biotechnology Co Ltd: Expects to Report Net Loss of About $1.09 Million for Year Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656399053","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656399053?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529916,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656722399","title":"Cellyan Biotechnology Flags Delay in Filing Annual Form 20-F for FY Ended March 31, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656722399","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656722399?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:31","pubTimestamp":1785529866,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology flags delay in filing annual Form 20-F for FY ended March 31, 2026Cellyan Biotechnology filed a Form 12b-25 to delay its annual Form 20-F for the year ended March 31, 2026.Delay ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL9zH1Lc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652400162","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2652400162","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652400162?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:32","pubTimestamp":1784287976,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology  shares were down 21% in Friday premarket trading after the company said Nasdaq granted it an additional 180-day grace period to regain compliance with the exchange's minimum bid price requirement.Eva Live  stock was down 18%, extending the earlier session's 3.6% decline.Regenxbio  shares were down 17% after the company priced an underwritten public offering of common shares and pre-funded warrants.Research Frontiers  stock was down 17%, adding to Thursday's 3.9% loss.Cycurion  shares were down 15% after the company said it received a Nasdaq delisting determination letter.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RGNX","BK4563","HKPD","BK4505","BK4157","CYCU","REFR","BK4139","BK4123","GOAI","BK4009","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652427027","title":"Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2652427027","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652427027?lang=en_us&edition=fundamental","pubTime":"2026-07-17 05:57","pubTimestamp":1784239062,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology (HKPD) has been granted an additional 180-day grace period by Nasdaq to regain compliance with the exchange's minimum bid-price requirement.The extension runs through Jan. 11, Cellyan said Thursday in a statement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","HKPD","LCLG","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422523","title":"Cellyan Biotechnology Co., Ltd Receives NASDAQ Notice of Additional Compliance Grace Period","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422523?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:30","pubTimestamp":1784233800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUA2RTCTT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643218053","title":"Cellyan Biotechnology Files $200 Million Mixed Shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2643218053","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643218053?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:48","pubTimestamp":1781297284,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology (HKPD) on Friday filed a shelf registration statement for the potential sale of up to $200 million of its securities from time to time.The filing covers Class A shares, debt securities, warrants, rights and units.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643921826","title":"Cellyan Biotechnology files $200M mixed securities shelf","url":"https://stock-news.laohu8.com/highlight/detail?id=2643921826","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643921826?lang=en_us&edition=fundamental","pubTime":"2026-06-13 04:36","pubTimestamp":1781296566,"startTime":"0","endTime":"0","summary":"16:32 EDT Cellyan Biotechnology (HKPD) files $200M mixed securities shelf Published first on TheFly – the ultimate source for real-time, market-mov...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-files-200m-mixed-securities-shelf-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642267528","title":"Cellyan Biotechnology director Chan Kam Leung files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642267528","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642267528?lang=en_us&edition=fundamental","pubTime":"2026-06-12 19:02","pubTimestamp":1781262121,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology filed an initial Form 3 showing director Kam Leung Chan as a reporting insider on March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260612:nNDL9Gw2mk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642473427","title":"Cellyan Biotechnology files Form 3 showing director Wong Lap Sun stake of 18,468 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2642473427","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642473427?lang=en_us&edition=fundamental","pubTime":"2026-06-11 03:11","pubTimestamp":1781118673,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology director Wong Lap Sun reported direct ownership of 18,468 Class A Ordinary Shares in an initial SEC Form 3 filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 10, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260610:nNDL1YnvH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642843611","title":"Cellyan Biotechnology CEO and Director Andy Liang files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2642843611","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642843611?lang=en_us&edition=fundamental","pubTime":"2026-06-09 02:23","pubTimestamp":1780943030,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology filed a Form 3 naming CEO and director Liang Chenyu Andy as a reporting insider, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 08, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL3xfb3d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629985641","title":"Indef: EV Tax Policy Creates Loopholes for Tax Avoidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2629985641","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629985641?lang=en_us&edition=fundamental","pubTime":"2026-04-23 19:32","pubTimestamp":1776943939,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta -The Ministry of Home Affairs has granted regional governments the authority to levy taxes on electric vehicles  through Ministerial Regulation Number 11 of 2026. Under this new mandate, electric cars and motorcycles are no longer exempt from Motor Vehicle Tax  and Motor Vehicle Transfer Fees .However, Andry Satrio Nugroho, an economist at the Institute for Development of Economics and Finance , argues that the policy requires a review due to several inherent complications. One of them is a potential conflict with Law Number 1 of 2022 regarding Financial Relations between the Central and Regional Governments , where Article 7 explicitly stipulates that renewable energy-based vehicles remain exempt from PKB.","market":"sh","thumbnail":"https://statik.tempo.co/data/2026/04/19/id_1469547/1469547_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/04/19/id_1469547/1469547_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2099997/indef-ev-tax-policy-creates-loopholes-for-tax-avoidance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2099997/indef-ev-tax-policy-creates-loopholes-for-tax-avoidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4131","HKPD","PKB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622877229","title":"BRIEF-Cellyan Biotechnology Says Selling Shareholders May Offer 12.5 Mln Class A Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2622877229","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622877229?lang=en_us&edition=fundamental","pubTime":"2026-03-28 03:33","pubTimestamp":1774640009,"startTime":"0","endTime":"0","summary":"BRIEF-Cellyan Biotechnology Says Selling Shareholders May Offer 12.5 Mln Class A Ordinary SharesMarch 27  - Cellyan Biotechnology Co Ltd HKPD.O:CELLYAN BIOTECHNOLOGY CO LTD - SELLING SHAREHOLDERS MAY OFFER UP TO 12.5 MILLION CLASS A ORDINARY SHARES FROM TIME TO TIME  - SEC FILINGSource text: [ID:n0001213900-26-035450]Further company coverage: HKPD.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622877045","title":"Cellyan Biotechnology Co. files to sell 12.5M Class A ordinary shares for holder","url":"https://stock-news.laohu8.com/highlight/detail?id=2622877045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622877045?lang=en_us&edition=fundamental","pubTime":"2026-03-28 03:25","pubTimestamp":1774639514,"startTime":"0","endTime":"0","summary":"15:22 EDT Cellyan Biotechnology Co. (HKPD) files to sell 12.5M Class A ordinary shares for holder Published first on TheFly – the ultimate source f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-co-files-to-sell-12-5m-class-a-ordinary-shares-for-holder-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cellyan-biotechnology-co-files-to-sell-12-5m-class-a-ordinary-shares-for-holder-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622877197","title":"Cellyan Biotechnology Co Ltd - Selling Shareholders May Offer up to 12.5 Mln Class a Ordinary Shares From Time to Time  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622877197","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622877197?lang=en_us&edition=fundamental","pubTime":"2026-03-28 03:20","pubTimestamp":1774639255,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622684746","title":"Cellyan Biotechnology sells 12,499,986 units in private placement; gross proceeds rise to $7 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2622684746","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622684746?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:03","pubTimestamp":1774605819,"startTime":"0","endTime":"0","summary":"Cellyan entered securities purchase agreements with certain investors for a private placement of 12,499,986 units at USD 0.52 per unit.The company reported gross proceeds of about USD 6.5 million from the unregistered sale.Each unit includes one Class A ordinary share and two warrants with a USD 0.01 per share exercise price.The private placement closed on March 25, 2026, and was conducted under Securities Act exemptions in Section 4 and Regulation S.Cellyan said it plans to use the proceeds for business expansion and working capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cellyan Biotechnology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL6zvZ3w:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HKPD","BK4131"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620326201","title":"Cellyan Biotechnology H1 FY2025 revenue fell 36% to USD 7.14 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2620326201","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620326201?lang=en_us&edition=fundamental","pubTime":"2026-03-19 04:33","pubTimestamp":1773866034,"startTime":"0","endTime":"0","summary":"Cellyan Biotechnology published an unaudited Form 6-K with condensed consolidated financial statements for the six months ended Sept. 30. Revenue fell 35.65% to USD 7.14 million, while net profit attributable to owners dropped 81.45% to USD 153,735. Operating profit declined 77.19% to USD 234,319, and profit before income taxes decreased 82.45% to USD 171,802. On the balance sheet, total assets were USD 9.63 million and cash and cash equivalents were USD 190,912 as of Sept. 30, 2025. After the period, Cellyan said it submitted an early redemption application for its open-ended fund investment totaling USD 2.33 million and had received the first two installments of the redemption proceeds in full as of March 18, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL3frcR4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4131","HKPD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}